COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,043 Articles (22,627 medRxiv, 8,416 bioRxiv)

Most recent first Previous |  Page 2225: Articles 22241-22250  | Next

Pre-existing T cell memory as a risk factor for severe 1 COVID-19 in the elderly
Bacher, P., Rosati, E., Esser, D., Rios Martini, G., Saggau, C., Schiminsky, E., Dargvainiene, J., Schröder, I., Wieters, I., Eberhardt, F., Neb, H., Khodamoradi, Y., Sonntagbauer, M., Vehreschild, M. J., Conrad, C., Tran, F., Rosenstiel, P., Markewitz, R., Wandinger, K.-P., Rybniker, J., Kochanek, M., Leypoldt, F., Cornely, O. A., Koehler, P., Franke, A., Scheffold, A.
10.1101/2020.09.15.20188896 — Posted: 2020-09-18
Pentoxifylline and Covid-19: A Systematic Review
Ramonfaur, D., Gonzalez, C. A., Paredes-Vazquez, J. G.
10.1101/2020.09.14.20194381 — Posted: 2020-09-18
Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin
Emmerich, P., Murawski, C., von Possel, R., Oestereich, L., Duraffour, S., Pahlmann, M., Struck, N. S., Eibach, D., Krumkamp, R., Amuasi, J., Maiga-Ascofare, O., Rakotozandrindrainy, R., Asogun, D., Ighodalo, Y., May, J., Tannich, E., Deschermeier, C.
10.1101/2020.09.15.20159749 — Posted: 2020-09-18
Early Release Estimates for SARS-CoV-2 Prevalence and Antibody Response Interim Weighting for Probability-Based Sample Surveys
Bradley, H., Fahimi, M., Sanchez, T., Lopman, B., Frankel, M., Kelley, C., Rothenberg, R., Siegler, A. J., Sullivan, P. S.
10.1101/2020.09.15.20195099 — Posted: 2020-09-18
First detection of SARS-CoV-2 genetic material in the vicinity of COVID-19 isolation centre through wastewater surveillance in Bangladesh
Ahmed, F., Islam, M. A., Kumar, M., Hossain, M., Bhattachariya, P., Islam, M. T., Hossen, F., Hossain, M. S., Uddin, M. M., Islam, M. N., Bahadur, N. M., Alam, M. D. u., Reza, H. M., Jakariya, M.
10.1101/2020.09.14.20194696 — Posted: 2020-09-18
Non-stationary Spatio-Temporal Modeling of COVID-19 Progression in The U.S.
Bai, Y., Safikhani, A., Michailidis, G.
10.1101/2020.09.14.20194548 — Posted: 2020-09-18
Dual Attention Multiple Instance Learning with Unsupervised Complementary Loss for COVID-19 Screening
Chikontwe, P., Luna, M., Kang, M., Hong, K. S., Ahn, J. H., Park, S. H.
10.1101/2020.09.14.20194654 — Posted: 2020-09-18
A comparative study and application of modified SIR and Logistic models at Municipal Corporation level database of CoViD-19 in India
Bajaj, N. S., Pardeshi, S. S., Patange, A. D., Khade, H. S., Mate, K. K.
10.1101/2020.09.12.20193375 — Posted: 2020-09-18
Strict lockdown versus flexible social distance strategy for COVID-19 disease: a cost-effectiveness analysis
Mol, B. W., Karnon, J.
10.1101/2020.09.14.20194605 — Posted: 2020-09-18
Genetically proxied inhibition of interleukin-6 signaling: opposing associations with susceptibility to COVID-19 and pneumonia
Larsson, S. C., Burgess, S., Gill, D. C.
10.1101/2020.09.15.20165886 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).